主動脈瓣置換裝置市場規模、佔有率和成長分析：按產品類型、材料類型、手術方法、應用、最終用戶、年齡層和地區分類－2026-2033年產業預測

2024 年全球主動脈瓣置換裝置市值為 75 億美元，預計到 2025 年將成長至 82.9 億美元，到 2033 年將成長至 184.2 億美元，預測期（2026-2033 年）複合年成長率為 10.5%。

主動脈瓣膜置換器械市場正受到主動脈瓣狹窄發病率上升的顯著影響，而主動脈瓣狹窄的發病率上升又與人口老化以及診斷技術的進步密切相關，診斷技術的進步擴大了治療範圍。由於未經治療的瓣膜性心臟病會導致嚴重的健康問題和高昂的醫療費用，該市場涵蓋了外科手術和經導管瓣膜、輸送系統以及影像技術。在領導企業技術創新的推動下，市場正從傳統的外科手術方法轉向經導管治療，從而改變治療方案，並為高風險患者提供更多治療選擇。技術進步正在最大限度地降低手術風險，促進臨床醫生接受相關技術，並獲得保險公司的支持。此外，人工智慧透過自動化影像分析和預測建模，正在改善患者選擇和治療效果。這有助於及時評估和提高工作流程效率，最終促進市場成長並提高患者照護效率。

全球二尖瓣置換裝置市場的成長要素

全球主動脈瓣置換器械市場正受到瓣膜設計、輸送機制和影像技術進步的顯著推動，這些進步提高了手術可靠性和臨床療效。這些創新正在擴大醫療專業人員和患者的接受度。此外，器械材料的改進和低輪廓輸送系統的開發，拓展了微創手術的選擇範圍，使其惠及高風險患者，從而增強了臨床醫生的信心和轉診意願。製造商的持續創新創造了一種鼓勵投資於培訓和醫院基礎設施的環境，隨著更多手術被接受，患者也逐漸認知到治療益處，這反過來又推動了市場成長。

全球二尖瓣置換裝置市場的限制因素

全球主動脈瓣置換器械市場面臨諸多限制因素，阻礙其擴張。這些限制因素主要源自於手術操作的複雜性以及有效實施手術所需的大量實務訓練。這種複雜性通常需要醫療機構和專業團隊的支持，限制了普通醫院的廣泛應用，導致服務集中在手術量大的醫療機構。因此，不同地區的患者就醫機會有限。此外，由於醫師經驗的差異，治療結果​​的差異性也會對轉診率和保險公司的報銷意願產生負面影響。因此，儘管臨床對瓣膜置換解決方案的需求仍然存在，但市場成長緩慢。此外，與認證相關的行政挑戰以及多學科協作的需求也延緩了專案的建立，進一步阻礙了市場發展。

二尖瓣置換裝置的全球市場趨勢

全球二尖瓣置換器械市場正經歷微創手術應用的激增，這反映了旨在改善患者預後的臨床趨勢。由於恢復時間更短、住院時間更短以及患者舒適度更高，醫生更傾向於選擇創傷較小的手術方式。這種轉變促使醫療機構將經導管介入治療納入治療方案，從而擴大了適用這些先進介入治療的患者群體。因此，醫療服務領域的投資顯著增加，並建立了專注於導管技術研發的多學科協作中心。保險公司和醫院也正在重新審視其治療方案和選擇標準，以滿足日益成長的微創技術需求，最終目標是精簡機構流程，並將以患者為中心的醫療服務放在首位。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球主動脈瓣置換裝置市場規模：依產品類型分類

• 用於外科主動脈瓣置換術（SAV​​R）的器械
• 經導管主動脈瓣置換術（TAVR）裝置
• 機械閥
• 組織瓣膜/生物人工瓣膜
• 其他

全球主動脈瓣置換裝置市場規模：依材料類型分類

• 機械材料
• 生物組織材料
• 聚合物基材料
• 其他

全球主動脈瓣置換裝置市場規模：依手術類型分類

• 微創手術
• 開胸手術

全球主動脈瓣置換裝置市場規模：依應用領域分類

• 主動脈瓣狹窄
• 主動脈瓣逆流
• 先天性主動脈瓣疾病
• 其他

全球主動脈瓣置換裝置市場規模：依最終用戶分類

• 醫院
• 心臟中心
• 門診手術中心
• 專科診所
• 其他

全球主動脈瓣置換裝置市場規模：依年齡層別分類

• 成人
• 兒童
• 老年人

全球主動脈瓣置換裝置市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• JenaValve Technology, Inc.
• Meril Life Sciences Pvt. Ltd.
• LivaNova PLC
• CryoLife, Inc.
• Artivion, Inc.
• Braile Biomedica
• Colibri Heart Valve LLC
• Lepu Medical Technology（Beijing）Co., Ltd.
• Venus Medtech（Hangzhou）Inc.
• Peijia Medical Limited
• MicroPort Scientific Corporation
• JC Medical, Inc.
• Foldax, Inc.
• Anteris Technologies Ltd.
• Balton Sp. z oo
• TTK Healthcare Limited

結論與建議

Global Aortic Valve Replacement Devices Market size was valued at USD 7.5 Billion in 2024 and is poised to grow from USD 8.29 Billion in 2025 to USD 18.42 Billion by 2033, growing at a CAGR of 10.5% during the forecast period (2026-2033).

The aortic valve replacement devices market is significantly influenced by the increasing incidence of aortic stenosis among aging populations and advancements in diagnostic capabilities, which have broadened intervention eligibility. This market encompasses surgical and transcatheter valves, delivery systems, and imaging technologies, given that untreated valve disease leads to serious health issues and high healthcare costs. A transition from traditional surgical methods to transcatheter options, largely driven by innovations from leading companies, has transformed treatment protocols and extended care to higher-risk patients. Technological advancements minimize procedural risks, fostering clinician adoption and payer endorsement. Moreover, AI is enhancing patient selection and outcomes by automating imaging analysis and predictive modeling, promoting timely evaluations and streamlined workflows that ultimately bolster market growth and efficiency in patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aortic Valve Replacement Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aortic Valve Replacement Devices Market Segments Analysis

Global aortic valve replacement devices market is segmented by product type, material type, procedure type, application, end user, age group and region. Based on product type, the market is segmented into Surgical Aortic Valve Replacement (SAVR) Devices, Transcatheter Aortic Valve Replacement (TAVR) Devices, Mechanical Valves, Tissue/Bioprosthetic Valves and Others. Based on material type, the market is segmented into Mechanical Materials, Biological Tissue Materials, Polymer-Based Materials and Others. Based on procedure type, the market is segmented into Minimally Invasive Procedures and Open Heart Surgery. Based on application, the market is segmented into Aortic Stenosis, Aortic Regurgitation, Congenital Aortic Valve Disorders and Others. Based on end user, the market is segmented into Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Specialty Clinics and Others. Based on age group, the market is segmented into Adult, Pediatric and Geriatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aortic Valve Replacement Devices Market

The Global Aortic Valve Replacement Devices market is significantly driven by advancements in valve designs, delivery mechanisms, and imaging technologies that improve procedural reliability and clinical results. These innovations have led to greater adoption of these devices among healthcare professionals and patients alike. Additionally, enhancements in device materials and the creation of lower-profile delivery systems have broadened the options for minimally invasive procedures, making them accessible to patients with high-risk profiles, which boosts clinician confidence and referral behavior. Continuous innovation by manufacturers fosters an environment of training and investment in hospital infrastructure, thereby reinforcing market growth as more procedures gain acceptance and patients recognize their therapeutic benefits.

Restraints in the Global Aortic Valve Replacement Devices Market

The Global Aortic Valve Replacement Devices market faces several restraints that hinder its expansion, primarily due to the intricate procedural requirements and the significant hands-on training necessary for effective implementation. This complexity often necessitates institutional backing and specialized teams, limiting widespread adoption in general hospitals and leading to a concentration of services in high-volume facilities, which restricts access for patients in various regions. Additionally, differences in operator experience can result in inconsistent outcomes, negatively impacting referral rates and reimbursement willingness, thus slowing market growth despite the existing clinical demand for valve replacement solutions. Furthermore, the administrative challenges related to credentialing and the need for multidisciplinary coordination can delay the establishment of programs, further impeding progress in the market.

Market Trends of the Global Aortic Valve Replacement Devices Market

The Global Aortic Valve Replacement Devices market is witnessing a surge in the adoption of minimally invasive procedures, reflecting a clinical trend towards enhanced patient outcomes. Physicians favor less invasive options for their quicker recovery times, shorter hospital stays, and improved patient comfort. This shift is prompting healthcare providers to incorporate transcatheter approaches into their treatment protocols, broadening the range of patients eligible for these advanced interventions. Consequently, there is a significant increase in investments in service lines and the establishment of multidisciplinary centers that focus on developing catheter-based skills. Payers and hospitals are also evolving care protocols and selection criteria to align with the growing preference for minimally invasive techniques, ultimately aiming to enhance institutional efficiency and prioritize patient-centered care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Aortic Valve Replacement Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Surgical Aortic Valve Replacement (SAVR) Devices
• Transcatheter Aortic Valve Replacement (TAVR) Devices
• Mechanical Valves
• Tissue/Bioprosthetic Valves
• Others

Global Aortic Valve Replacement Devices Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Mechanical Materials
• Biological Tissue Materials
• Polymer-Based Materials
• Others

Global Aortic Valve Replacement Devices Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Minimally Invasive Procedures
• Open Heart Surgery

Global Aortic Valve Replacement Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Aortic Stenosis
• Aortic Regurgitation
• Congenital Aortic Valve Disorders
• Others

Global Aortic Valve Replacement Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Global Aortic Valve Replacement Devices Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adult
• Pediatric
• Geriatric

Global Aortic Valve Replacement Devices Market Size & CAGR (2026-2033)

• North America (Product Type, Material Type, Procedure Type, Application, End User, Age Group)
  • US
  • Canada
• Europe (Product Type, Material Type, Procedure Type, Application, End User, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, Procedure Type, Application, End User, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, Procedure Type, Application, End User, Age Group)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, Procedure Type, Application, End User, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JC Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foldax, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anteris Technologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balton Sp. z o.o.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations